08:55 AM EDT, 09/20/2024 (MT Newswires) -- NovaBay Pharmaceuticals ( NBY ) shares were up 77% premarket Friday after the company said it signed a deal to sell its Avenova brand and assets to an Acumen Health unit for $9.5 million in cash.

The transaction is expected to close in Q4, subject to approval by NovaBay shareholders and customary closing conditions.

Price: 0.8796, Change: +0.38, Percent Change: +77.02